Clinical trial
Effect of Probiotics on Systemic Inflammation and Insulin Resistance in Type 2 Diabetics and Healthy Controls
NCT00413348 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Probiotics on Systemic Inflammation and Insulin Resistance in Type 2 Diabetics and Healthy Controls
- Lead sponsor
- Rigshospitalet, Denmark
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 30, 2006
- Completion date
- December 31, 2007
- Enrollment
- 48
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
endotoxemia, healthy, type 2 diabetes